Edifice Health

About Edifice Health

Edifice Health provides the Inflammatory Age® test, a biomarker composite scoring system developed from a decade-long NIH-funded study, to measure and monitor systemic chronic inflammation. This technology enables healthcare providers to identify and manage chronic inflammation, which is linked to age-related diseases and overall health deterioration.

```xml <problem> Systemic chronic inflammation is a root cause of many age-related diseases and overall health deterioration, but it is difficult to measure and monitor effectively with traditional methods. This lack of precise monitoring hinders proactive management and early detection of inflammation-related health issues. </problem> <solution> Edifice Health offers the Inflammatory Age® test, a biomarker composite scoring system derived from a decade-long NIH-funded study, to quantify and track systemic chronic inflammation. Using advanced 'omics' platforms and artificial intelligence, the test provides insights into an individual's inflammatory and immune health. The Inflammatory Age® metric predicts multi-morbidity, immune function, and cumulative physiological damage, offering previously unattainable insights into biological health. By partnering with clinics and physicians, Edifice Health aims to facilitate early detection and prevention of disease through proactive management of chronic inflammation. </solution> <features> - Biomarker composite scoring system for measuring systemic chronic inflammation - Derived from a 10-year NIH-funded longitudinal research study (Stanford 1,000 Immunomes Project) - Utilizes state-of-the-art 'omics' platforms and advanced artificial intelligence methods - Provides an Inflammatory Age® metric that predicts multi-morbidity, immune function, and cumulative physiological damage </features> <target_audience> The primary target audience includes healthcare providers focusing on early detection and prevention of disease, as well as individuals interested in proactively managing their inflammatory health for better overall health and longevity. </target_audience> ```

What does Edifice Health do?

Edifice Health provides the Inflammatory Age® test, a biomarker composite scoring system developed from a decade-long NIH-funded study, to measure and monitor systemic chronic inflammation. This technology enables healthcare providers to identify and manage chronic inflammation, which is linked to age-related diseases and overall health deterioration.

Where is Edifice Health located?

Edifice Health is based in San Mateo, Philippines.

When was Edifice Health founded?

Edifice Health was founded in 2018.

How much funding has Edifice Health raised?

Edifice Health has raised 15700000.

Location
San Mateo, Philippines
Founded
2018
Funding
15700000
Employees
5 employees
Major Investors
Leaps by Bayer

Find Investable Startups and Competitors

Search thousands of startups using natural language

Edifice Health

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Edifice Health provides the Inflammatory Age® test, a biomarker composite scoring system developed from a decade-long NIH-funded study, to measure and monitor systemic chronic inflammation. This technology enables healthcare providers to identify and manage chronic inflammation, which is linked to age-related diseases and overall health deterioration.

edificehealth.com700+
cb
Crunchbase
Founded 2018San Mateo, Philippines

Funding

$

Estimated Funding

$10M+

Major Investors

Leaps by Bayer

Team (5+)

No team information available.

Company Description

Problem

Systemic chronic inflammation is a root cause of many age-related diseases and overall health deterioration, but it is difficult to measure and monitor effectively with traditional methods. This lack of precise monitoring hinders proactive management and early detection of inflammation-related health issues.

Solution

Edifice Health offers the Inflammatory Age® test, a biomarker composite scoring system derived from a decade-long NIH-funded study, to quantify and track systemic chronic inflammation. Using advanced 'omics' platforms and artificial intelligence, the test provides insights into an individual's inflammatory and immune health. The Inflammatory Age® metric predicts multi-morbidity, immune function, and cumulative physiological damage, offering previously unattainable insights into biological health. By partnering with clinics and physicians, Edifice Health aims to facilitate early detection and prevention of disease through proactive management of chronic inflammation.

Features

Biomarker composite scoring system for measuring systemic chronic inflammation

Derived from a 10-year NIH-funded longitudinal research study (Stanford 1,000 Immunomes Project)

Utilizes state-of-the-art 'omics' platforms and advanced artificial intelligence methods

Provides an Inflammatory Age® metric that predicts multi-morbidity, immune function, and cumulative physiological damage

Target Audience

The primary target audience includes healthcare providers focusing on early detection and prevention of disease, as well as individuals interested in proactively managing their inflammatory health for better overall health and longevity.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.